Evidence map›Paper›PMID 17479263›Full record

ReviewEuropean journal of nuclear medicine and molecular imaging2007

Metabolic imaging using SPECT.

Junichi Taki, Ichiro Matsunari

Abstract readReview
PubMed Publisher
In one paragraph

Review in European journal of nuclear medicine and molecular imaging, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Metabolic Imaging in Cardio-oncology.Journal of cardiovascular translational research · 2020
    Review
  3. Article
  4. Article
  5. Article
  6. Direct imaging of myocardial ischemia: a potential new paradigm in nuclear cardiovascular imaging.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
    Article
  7. Article
  8. Non-invasive imaging of microvascular damage.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Junichi TakiDepartment of Biotracer Medicine, Kanazawa University Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa 920-8640, Japan. taki@med.kanazawa-u.ac.jp
Ichiro Matsunari

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn normal condition, the heart obtains more than two-thirds of its energy from the oxidative metabolism of long chain fatty acids, although a wide variety of substrates such as glucose, lactate, ketone bodies and amino acids are also utilised. In ischaemic myocardium, on the other hand, oxidative metabolism of free fatty acid is suppressed and anaerobic glucose metabolism plays a major role in residual oxidative metabolism. Therefore, metabolic imaging can be an important technique for the assessment of various cardiac diseases and conditions. MATERIALS AND

methodsIn SPECT, several iodinated fatty acid traces have been introduced and studied. Of these, (123)I-labelled 15-(p-iodophenyl)3-R, S-methylpentadecanoic acid (BMIPP) has been the most commonly used tracer in clinical studies, especially in some of the European countries and Japan. RESULTS AND DISCUSSION: In this review article, several fatty acid tracers for SPECT are characterised, and the mechanism of uptake and clinical utility of BMIPP are discussed in detail.

Indexed as

IodobenzenesFatty AcidsHeartHeart DiseasesHumansMyocardiumRadiopharmaceuticalsTomography, Emission-Computed, Single-PhotonFatty AcidsIodobenzenesiodofiltic acidRadiopharmaceuticals

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.